Tag Archives: Lapitinib
HER2-positive Breast Cancer with Brain Metastases? Use Lapitinibi (Tykerb) and Capecitibine (Xeloda) but NOT Trastuzumab (Herceptin)
Human epidermal growth factor receptor 2-positive (HER2+) breast cancer (BC) is a disease that accounts for up to one third of all invasive breast tumors. The natural history of this disease, however, has been dramatically improved with the introduction of … Continue reading →
Posted in Breast cancer, Cancer
|
Tagged Brain metastases, Breast cancer, Capecitibine, Her2, Herceptin, Lapitinib, Metastatic breast cancer, Survival, Trastuzumab, Tykerb, Xeloda
|
Comments Off on HER2-positive Breast Cancer with Brain Metastases? Use Lapitinibi (Tykerb) and Capecitibine (Xeloda) but NOT Trastuzumab (Herceptin)